German Food and Staples Retail Stock News

DB:BFV
DB:BFVCapital Markets

Berliner Effektengesellschaft (DB:BFV) After Strong Half Year Earnings Still Looks Pricey

Berliner Effektengesellschaft (DB:BFV) has drawn fresh attention after reporting half year 2026 net income of €23.72 million, compared with €14.07 million for the same period a year earlier. See our latest analysis for Berliner Effektengesellschaft. Despite the stronger half year 2026 results, Berliner Effektengesellschaft's recent price performance has been muted. The 30 day share price return declined 0.68% and the 90 day share price return declined 1.35%, while the 1 year total shareholder...
XTRA:PCZ
XTRA:PCZBanks

3 European Dividend Stocks Yielding Up To 5.7%

As the European markets navigate a landscape marked by resilient economic data and geopolitical uncertainties, investors are increasingly turning their attention to dividend stocks as a potential source of steady income. In this environment, selecting stocks with strong fundamentals and reliable dividend yields can offer a degree of stability amid market fluctuations.
XTRA:EOAN
XTRA:EOANIntegrated Utilities

E.ON (XTRA:EOAN) Q2 Results Put Its Undervalued Narrative Back In Focus

Why E.ON stock is back in focus after Q2 2026 results E.ON (XTRA:EOAN) is drawing fresh attention after reporting its second quarter and first half 2026 earnings. Quarterly sales and profit were broadly steady year on year, while first half net income moved sharply higher. See our latest analysis for E.ON. E.ON's share price has pulled back recently, with a 30 day share price return of down 8.9% and a 90 day share price return of down 4.1%. However, the 1 year total shareholder return of...
XTRA:NA9
XTRA:NA9IT

Nagarro (XTRA:NA9) Lifted Half Year Profitability, Is The Recent Strength Fully Priced?

Profitability jump at Nagarro after half year results Nagarro (XTRA:NA9) is back on investor radars after half year 2026 figures showed higher net income and earnings per share, while sales remained broadly stable compared with the same period a year earlier. See our latest analysis for Nagarro. The stronger half year profitability appears to have come on the back of already improving sentiment, with Nagarro’s 90 day share price return of 91.7% pointing to building momentum. At the same time,...
XTRA:S92
XTRA:S92Electrical

SMA Solar Technology (XTRA:S92) Could Be 9% Undervalued As Earnings Turned Positive

SMA Solar Technology (XTRA:S92) drew fresh investor attention after reporting second quarter 2026 earnings that shifted from a loss to a profit, even though sales stayed close to the prior year’s level. See our latest analysis for SMA Solar Technology. SMA Solar Technology’s earnings swing back to profit came after a strong year to date, with a share price return of 61.07% in 2026 and a one year total shareholder return of 154.64%. However, the 90 day share price return of 14.92% indicates...
XTRA:G1A
XTRA:G1AMachinery

GEA Group (XTRA:G1A) Is Back In The Spotlight

GEA Group (XTRA:G1A) is back in focus after reporting second quarter and half year 2026 results that show higher sales, net income and earnings per share compared with the previous year’s figures. See our latest analysis for GEA Group. The share price of GEA Group is at €64.95 after a 30 day share price return of 9.62% and a 90 day share price return of 19.72%. The 3 year total shareholder return of 94.05% and 5 year total shareholder return of 87.16% point to stronger longer term...
XTRA:HTG
XTRA:HTGHospitality

HomeToGo (XTRA:HTG) Stock Price Falls As Revenue Jumps But Losses Deepen

HomeToGo came into this earnings print as a deeply out of favour travel stock, with the share price down roughly 25% over the past three months and trading at about €0.91. The market has been treating it like a low growth, subscale platform. The headline from Q2 tells a different story. Revenue reached €101.04 million and the company reported a loss of €8.764 million, while adjusted EBITDA for the first half improved to a loss of €15.1 million, alongside positive unlevered free cash flow of...
XTRA:BMW
XTRA:BMWAuto

Bayerische Motoren Werke (XTRA:BMW) After Ionchi Approval Is The Valuation Case Still Open

The recent European Commission approval of a joint venture controlling Beijing IONCHI New Energy Technology puts Bayerische Motoren Werke (XTRA:BMW) in focus, as investors weigh the stock against China’s expanding ultra fast charging buildout. See our latest analysis for Bayerische Motoren Werke. Bayerische Motoren Werke shares trade at €57.86, with the stock showing a 1-year total shareholder return of 32.33% and a 3-year total shareholder return of 29.16%, suggesting recent price weakness...
XTRA:HDD
XTRA:HDDMachinery

Heidelberg (XTRA:HDD) Stock Price Faces Margin Collapse And Rising Losses

Heidelberger Druckmaschinen walked into this earnings day priced for distress, with the stock at €1.40 and a weak short term return profile over the past week. The market has treated it as a cheap cyclical print supplier. The Q1 numbers instead spotlight a sharper profitability squeeze than that simple value story suggests. Sales fell to €404m while adjusted EBITDA margin slid to just 0.2%. That drop in earnings power, not the top line alone, is what now challenges the easy “deep value”...
XTRA:DR0
XTRA:DR0Oil and Gas

Deutsche Rohstoff (XTRA:DR0) Stock Keeps Value Appeal Despite Slower Profit Momentum

Deutsche Rohstoff stock came into this earnings print looking like a deep value outlier, trading on about 3x trailing P/E while carrying a 12‑month revenue base above €300m and a net margin above 40%. The headline from Q2 is simple. Profit momentum slowed sharply against Q1, yet earnings over the past year still sit far above the prior period and keep that low multiple in focus. With the share price at €93.40 after the first full day of trading post release, the key question now is how...
XTRA:BOSS
XTRA:BOSSLuxury

Hugo Boss (XTRA:BOSS) Stock Looks Near Fair Value As Earnings Lag News

After a difficult three years in which Hugo Boss shares have fallen about 41.6%, the stock now trades around €37.59 and the valuation checks point to a picture that looks neither clearly cheap nor clearly expensive. The share price decline of about 41.6% over three years suggests long term holders have absorbed a significant drawdown that raises the bar for any fresh investment case. Frasers Group lifting its stake to nearly 48% can support confidence in Hugo Boss, while ongoing challenges...
XTRA:WAC
XTRA:WACMachinery

Wacker Neuson (XTRA:WAC) Could Be 8% Undervalued As Earnings Improve

Wacker Neuson (XTRA:WAC) released its second-quarter and half-year 2026 earnings on 13 August, reporting higher sales and net income compared with the same periods a year earlier. See our latest analysis for Wacker Neuson. At a share price of €20.85, Wacker Neuson has a 90 day share price return of 16.22%, while the year to date share price return is down 16.43% and the 3 year total shareholder return is 18.20%. This indicates that recent momentum has picked up following a weaker period. If...
XTRA:1SXP
XTRA:1SXPLife Sciences

SCHOTT Pharma KGaA (XTRA:1SXP) Reports Higher Sales And Lower Earnings, Is It Fully Valued?

SCHOTT Pharma KGaA (XTRA:1SXP) reported third quarter 2026 results that combined higher sales with weaker profitability, giving investors fresh numbers on revenue momentum and margin pressure as of June 30. See our latest analysis for SCHOTT Pharma KGaA. The latest earnings come against a backdrop of strong recent momentum in SCHOTT Pharma KGaA's share price, with a 90 day share price return of 36.55% and a year to date share price return of 54.55%, even though the 1 year total shareholder...
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank Stock And 2 EU Capital Markets Winners To Watch

With Christine Lagarde warning that Europe’s old growth engine is wearing out and policy makers floating ideas like an EU wide corporate form and deeper capital markets, the region’s big universal and investment banks sit at a crossroads. For investors, this mix of pressure and potential reform can create rare mispricing. This article walks through three EU banking stocks exposed to these shifts and explains what their capital markets focus may mean for how you think about your portfolio. The...
XTRA:MRK
XTRA:MRKPharmaceuticals

Is Merck KGaA (XTRA:MRK) Undervalued On Raised 2026 Guidance?

Merck KGaA (XTRA:MRK) recently raised its 2026 guidance, now expecting group net sales of about €21b to €21.8b and EPS pre of €7.90 to €8.60, which has refocused attention on the stock. See our latest analysis for Merck KGaA. At a share price of €138.35, Merck KGaA has seen a 9.45% 90 day share price return and a 14.06% year to date share price return. The 1 year total shareholder return of 26.40% contrasts with declines over 3 and 5 years, pointing to renewed but still fragile momentum after...
XTRA:WUW
XTRA:WUWInsurance

Wüstenrot & Württembergische (XTRA:WUW) Holds Earnings Guidance, Is The Valuation Gap Justified?

Wüstenrot & Württembergische (XTRA:WUW) has drawn fresh attention after reporting €104 million in half year net income and confirming its 2026 earnings guidance range of €120 million to €150 million. See our latest analysis for Wüstenrot & Württembergische. The recent confirmation of Wüstenrot & Württembergische’s 2026 earnings guidance came against a share price of €14.14, with the stock showing a modest 1 year total shareholder return of 2.39% and a 5 year total shareholder return that has...
XTRA:TEG
XTRA:TEGReal Estate

Is TAG Immobilien (XTRA:TEG) Fully Valued Following Mixed Second Quarter Results?

TAG Immobilien (XTRA:TEG) reported second quarter 2026 results, with sales of €130.02 million and net income of €76.45 million, as investors weigh higher revenue against lower earnings and earnings per share. See our latest analysis for TAG Immobilien. The mixed second quarter results come as TAG Immobilien’s share price has slipped recently, with a 7 day share price return of 5.24% and a 90 day share price return of 9.12%. The 3 year total shareholder return of 36.30% contrasts with a 1 year...
XTRA:PFSE
XTRA:PFSEElectrical

Three Undiscovered European Gems with Promising Potential

In recent weeks, the European market has shown resilience amid geopolitical uncertainties and fluctuating energy prices, with the STOXX Europe 600 Index experiencing a slight decline of 0.36%. As investors navigate these complex conditions, identifying stocks with strong fundamentals and growth potential becomes crucial; this article highlights three lesser-known European companies that may offer promising opportunities in such a dynamic environment.
XTRA:BNR
XTRA:BNRTrade Distributors

Is Brenntag (XTRA:BNR) Overvalued Following Strong Q2 Earnings?

Brenntag (XTRA:BNR) reported second quarter 2026 earnings that caught investor attention, with sales of €4,263 million and net income of €179 million, compared with €3,869 million and €42 million a year earlier. See our latest analysis for Brenntag. Brenntag’s recent earnings release comes after a period of firm share price momentum, with a year to date share price return of 24.38% and a 1 year total shareholder return of 16.91%, despite weaker total shareholder returns over 3 and 5 years. If...
XTRA:HEN3
XTRA:HEN3Household Products

Henkel KGaA (XTRA:HEN3) Faces A Valuation Check Following Softer Half Year Earnings

Henkel KGaA (XTRA:HEN3) reported half year 2026 earnings with sales of €10.35b and net income of €988m, both slightly lower than a year earlier. This earnings update is now in focus for investors. See our latest analysis for Henkel KGaA. Henkel KGaA shares trade at €75.52, with a 90 day share price return of 15.26% and year to date share price return of 8.41%, while the 1 year total shareholder return is 5.78%. This suggests momentum has picked up recently despite softer half year...
DB:PHH2
DB:PHH2Medical Equipment

Paul Hartmann (DB:PHH2) Stock Cheapens As Margin Debate Persists

Paul Hartmann stock came into this earnings season looking cheap on a P/E of 7.1x with a 4% dividend, yet shares have slipped over the past month and were down again around the results. The market is treating this as a value story that might never re rate. The headline from H1 says something different. Earnings per share for the half year landed at €15.35 on revenue of €1,251.95m. That supports trailing earnings of €28.13 per share and a trailing net margin of 4%. For a medical equipment...
XTRA:1U1
XTRA:1U1Wireless Telecom

1&1 (XTRA:1U1) Q2 Results Put Its Undervalued Narrative Back In Focus

Q2 results and steady 2026 guidance draw investor attention 1&1 (XTRA:1U1) caught investors’ attention after reporting second quarter 2026 results that showed higher sales but lower net income and earnings per share, alongside guidance for flat service revenue in 2026 versus 2025. See our latest analysis for 1&1. 1&1’s recent earnings and flat 2026 service revenue guidance come after a mixed price pattern, with the share price up 6% over the past week but down 14.86% year to date, while the 3...